ClearSeq Comprehensive Cancer
The ClearSeq Comprehensive Cancer targets 151 key genes associated with a wide range of cancers, including breast, lung, colorectal, and AML. This panel was developed in collaboration with cancer researchers from Washington University in St Louis, and is designed for deep coverage of target bases for confident variant detection.
The ClearSeq Comprehensive Cancer is compatible with the SureSelect Target Enrichment System, with options of post-capture and pre-capture pooling available.
For Research Use Only. Not for use in diagnostic procedures.